首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2019年 2期 胆汁淤积性肝病诊治的基础与临床 => 肝纤维化及肝硬化 =>FibroScan联..
FibroScan联合GGT/PLT比值预测慢性乙型肝炎患者肝纤维化的初步探讨
Value of FibroScan combined with gamma-glutamyl transpeptidase-to-platelet ratio in predicting liver fibrosis in patients with chronic hepatitis B: A preliminary study
文章发布日期:2019年01月07日  来源:  作者:黄春明,杨湛,聂玉强,等  点击次数:471次  下载次数:79次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:目的 初步探讨FibroScan联合GGT/PLT比值(GPR)预测慢性乙型肝炎(CHB)患者肝纤维化分期的诊断价值。方法 选取广州市第八人民医院2012年1月-2016年12月肝活组织检查诊断为CHB患者278例,分析GPR、FibroScan以及二者联合诊断预测纤维化分期(F0~F4)的价值。非正态分布的计量资料多组间比较采用Kruskal-Wallis H检验,进一步两两比较采用Mann-Whitney U检验。相关性分析采用Spearman相关系数。受试者工作特征曲线下面积(AUC)评估肝纤维化分期。结果 以肝活组织检查作为金标准,F1~F4期患者分别有50、104、92和32例。随着肝纤维化分期加重,FibroScan检测肝硬度值(LSM)逐渐升高(P值均<0.05);GPR在肝纤维化 F1、F2、F3期逐渐升高(P值均<0.05)。 GPR、FibroScan均与肝纤维化呈正相关(r值分别为0.419、0.481,P值均<0.001);GPR与FibroScan呈正相关(r=0.436,P<0.001)。FibroScan与GPR联合预测进展期肝纤维化(≥F3)的诊断效能优于单一FibroScan(AUC:0.793 vs 0.739,Z=3.044,P=0.002)或GPR(AUC:0.793 vs 0.740,Z=2.389,P=0.037);二者联合预测明显肝纤维化(≥F2)的诊断效能优于单一GPR(AUC:0.782 vs 0.714,Z=2.130,P=0.033)。结论 FibroScan与GPR联合诊断对于预测CHB进展期肝纤维化(≥F3)具有优势,初步认为可提高诊断效能。
【Abstract】:Objective To investigate the value of FibroScan combined with gamma-glutamyl transpeptidase-to-platelet ratio (GPR) in predicting liver fibrosis stage in patients with chronic hepatitis B (CHB). Methods A total of 278 patients who were diagnosed with CHB by liver biopsy in Guangzhou Eighth People’s Hospital from January 2012 to December 2016 were enrolled. The value of GPR and FibroScan used alone or in combination in predicting liver fibrosis stage (F0-F4) was analyzed. The Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between multiple groups and the Mann-Whitney U test was used for further comparison between two groups. The Spearman’s correlation coefficient was used for correlation analysis. The area under the receiver operating characteristic curve (AUC) was used to evaluate liver fibrosis stage. Results With liver biopsy as the gold standard, of all patients, 50 had stage F1 fibrosis, 104 had stage F2 fibrosis, 92 had stage F3 fibrosis, and 32 had stage F4 fibrosis. Liver stiffness measurement by FibroScan gradually increased with the increase in liver fibrosis stage (P<0.05), and GPR also increased gradually in patients with stage F1, F2, and F3 liver fibrosis (P<0.05). GPR and FibroScan were positively correlated with liver fibrosis (r=0.419 and 0.481, both P<0.001), and GPR was positively correlated with FibroScan (r=0.436, P<0.001). According to AUC, FibroScan combined with GPR had a better diagnostic efficiency than FibroScan (0.793 vs 0.739, Z=3.044, P=0.002) or GPR (0.793 vs 0.740, Z=2.389, P=0.037) alone in predicting progressive liver fibrosis (≥F3); FibroScan combined with GPR had a better diagnostic efficiency than GPR alone (0.782 vs 0.714, Z=2.130, P=0.033) in predicting marked liver fibrosis (≥F2). Conclusion FibroScan combined with GPR has a certain advantage in predicting progressive liver fibrosis (≥F3) in CHB patients and can improve diagnostic efficiency.
【关键字】:肝硬化; 肝炎, 乙型, 慢性; 弹性成像技术; γ-谷氨酰转移酶; 血小板; 诊断
【Key words】:liver cirrhosis; hepatitis B, chronic; elasticity imaging techniques; gamma-glutamyltransferase; blood platelets; diagnosis
【引证本文】:HUANG CM, YANG Z, NIE YQ, et al. Value of FibroScan combined with gamma-glutamyl transpeptidase-to-platelet ratio in predicting liver fibrosis in patients with chronic hepatitis B: A preliminary study[J]. J Clin Hepatol, 2019, 35(2): 334-337. (in Chinese)
黄春明,杨湛,聂玉强,等. FibroScan联合GGT/PLT比值预测慢性乙型肝炎患者肝纤维化的初步探讨[J]. 临床肝胆病杂志, 2019, 35(2): 334-337.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号